Avidity Partners Management LP Collegium Pharmaceutical, Inc Transaction History
Avidity Partners Management LP
- $2.03 Billion
- Q2 2024
A detailed history of Avidity Partners Management LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Avidity Partners Management LP holds 117,000 shares of COLL stock, worth $4.11 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
117,000
Previous 361,400
67.63%
Holding current value
$4.11 Million
Previous $14 Million
73.15%
% of portfolio
0.19%
Previous 0.54%
Shares
15 transactions
Others Institutions Holding COLL
# of Institutions
238Shares Held
39.3MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$204 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$120 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$92.6 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$83.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$82 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.2B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...